课题基金 / 基金详情

EyeStar-BIO: Software for Enhancing Digital Binocular Indirect Ophthalmoscopy Examinations

EyeStar-BIO: Software for Enhancing Digital Binocular Indirect Ophthalmoscopy Examinations
EyeStar-BIO:用于增强数字双目间接检眼镜检查的软件
批准号:
10824075
负责人:
Jeffrey Wigdahl
金额:
$5.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-06-01 至 2023-11-30

项目摘要

项目成果

Jeffrey Wigdahl的其他基金

相似基金

相关文献

中文摘要
翻译
总结 拟议项目的目标是开发EyeStar-BIO,这是一套软件工具,旨在增强数字化 双目间接检眼镜检查(BIO),检查的最常见形式之一, 视网膜。使用BIO,眼科医生可以确定多种视网膜疾病的存在,例如糖尿病视网膜病变。 视网膜病、黄斑变性和早产儿视网膜病等。传统的BIO考试 不产生任何视觉文件。 EyeStar-BIO将提供工具来增强数字BIO检查,例如:1)选择最佳质量的图像,2) 产生视网膜的宽视野视图,3)监测随时间的变化,以及4)诊断视网膜疾病 使用人工智能。 第一阶段项目的目标将通过三个具体目标实现: ·目标1:实现数字BIO视频帧的自动图像质量评估软件。 ·目标2:开发图像拼接方法以使用最佳质量生成视网膜的宽视场视图 视频中的帧。 ·目标3:生成图像以跟踪由于疾病进展或消退而导致的时间差异。 EyeStar-BIO软件将授权给数字BIO耳机制造商。未来的发展将 包括EyeStar-BIO的真实的实时实现和使用人工智能诊断视网膜疾病的能力。 智能
英文摘要
Summary The goal of the proposed project is to develop EyeStar-BIO, a suite of software tools designed to enhance digital binocular indirect ophthalmoscopy examinations (BIO), one of the most common forms of examination of the retina. Using BIO, an ophthalmologist can determine the presence of multiple retinal diseases such as diabetic retinopathy, macular degeneration, and retinopathy of prematurity, among others. The traditional BIO exam does not produce any visual documentation. EyeStar-BIO will provide tools to enhance digital BIO exams such as: 1) selecting best quality images, 2) generating a wide field view of the retina, 3) monitoring changes over time, and 4) diagnosing retinal diseases using artificial intelligence. The goals of this Phase I project will be accomplished via three specific aims: • Aim 1: implement software for automatic image quality assessment of digital BIO video frames. • Aim 2: develop image stitching methods to generate a wide field view of the retina using the best quality frames in the video. • Aim 3: generate images to track differences in time due to disease progression or regression. The EyeStar-BIO software will be licensed to manufacturers of digital BIO headsets. Future developments will include real time implementations of EyeStar-BIO and the ability to diagnose retinal disease using artificial intelligence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EyeStar-BIO: Software for Enhancing Digital Binocular Indirect Ophthalmoscopy Examinations
  • 批准号:
    10383202
  • 项目类别:
  • 资助金额:
    $24.76万
  • 财政年份:
    2022
  • 负责人:
    Jeffrey Wigdahl
  • 依托单位:
海外基金